<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04071834</url>
  </required_header>
  <id_info>
    <org_study_id>hanyi20190826</org_study_id>
    <nct_id>NCT04071834</nct_id>
  </id_info>
  <brief_title>Observation of Blood Orphanin and Norepinephrine Levels in Diabetic Patients Under Subarachnoid Anesthesia</brief_title>
  <official_title>Effect of Subarachnoid Anesthesia on Blood Orphanin and Norepinephrine in Diabetic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Hospital of Shanxi Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Hospital of Shanxi Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to investigate the Influence of Intraspinal anesthesia to the concentrations
      of blood orphanin, norepinephrine in patients with diabetes mellitus. We hope to explain the
      relationship between sensory and sympathetic nerves in diabetic patients undergoing
      intraspinal anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Actual">June 1, 2020</completion_date>
  <primary_completion_date type="Actual">April 2, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Blood orphanin concentration</measure>
    <time_frame>24 hours</time_frame>
    <description>Concentration of blood orphanin in patients before and after anesthesia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood norepinephrine concentration</measure>
    <time_frame>24 hours</time_frame>
    <description>Concentration of blood norepinephrine in patients before and after anesthesia</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">120</enrollment>
  <condition>Intraspinal Anesthesia</condition>
  <arm_group>
    <arm_group_label>Diabetes mellitus group</arm_group_label>
    <description>Diabetic patients undergoing spinal anesthesia for lower extremity surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-diabetic group</arm_group_label>
    <description>Non-diabetic patients undergoing spinal anesthesia for lower extremity surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>ELISA</intervention_name>
    <description>Detection of blood orphanin and norepinephrine in patients</description>
    <arm_group_label>Diabetes mellitus group</arm_group_label>
    <arm_group_label>Non-diabetic group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing lower limb surgery under spinal anesthesia

        Exclusion Criteria:

          -  Emergency surgery

          -  The operation time is more than 3 hours

          -  Combined general anesthesia or nerve block anesthesia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Second of Shanxi Medical University</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <zip>030001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>August 26, 2019</study_first_submitted>
  <study_first_submitted_qc>August 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2019</study_first_posted>
  <last_update_submitted>June 30, 2020</last_update_submitted>
  <last_update_submitted_qc>June 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Second Hospital of Shanxi Medical University</investigator_affiliation>
    <investigator_full_name>Zheng Guo</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

